Vaccine Adjuvant
Mannosylated lipid core peptides in liposomes elicit strong immune responses with Quil A adjuvant
Published in Cancer Weekly, September 5th, 2006
According to a report from New Zealand, "The purpose of this study was to investigate the immunogenicity of liposomes containing mannosylated lipid core peptide (manLCP) constructs, both in vitro and in vivo, with or without the addition of the immune stimulating adjuvant Quil A."
"Mouse bone marrow dendritic cells (BMDC) were cultured with liposome formulations for 48 hours, and the resulting level of BMDC activation was determined by flow cytometry," said Karen White and colleagues at the University of Otago...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-09-05)
More Articles from Cancer Weekly
- Childhood Cancer
Adult survivors of childhood cancer may be at risk of unemployment - Head & Neck Cancer
Head and neck squamous cell carcinoma risk reduced in smokers and drinkers by dietary antioxidants - Mental Health
Adults with serious mental illness have elevated cancer incidence - Prostate Cancer
Prostate cancer patients assessed for anxiety by Memorial Anxiety Scale for Prostate Cancer - Acid Reflux
Researchers discover how acid reflux leads to esophageal cancer - Acute Myeloid Leukemia
Dacogen (decitabine) for Injection receives U.S. orphan drug designation for patients with AML - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
